Status:
RECRUITING
Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation. The major goal of the project is to develop human iPS cells from various ty...
Detailed Description
The potential to reprogram somatic cells into an embryonic state raises multiple basic research questions related both to the process of reprogramming and the properties of iPS cells. We will use vari...
Eligibility Criteria
Inclusion
- Volunteers
- Male and Female
Exclusion
- Below the official age of consent
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00801333
Start Date
November 1 2008
End Date
December 1 2030
Last Update
March 5 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization - Ein Kerem Campus
Jerusalem, Israel, 91120
2
Hadassah Ein Kerem
Jerusalem, Israel, 9112100